Related Experiment Videos
Beta-blocker duration of action and implications for therapy
1Department of Medicine, University of Medicine and Dentistry, New Jersey, Robert Wood Johnson Medical School, New Brunswick 08903-0019.
The American Journal of Cardiology
|November 6, 1990
Summary
Beta blockers like nadolol demonstrate longer-lasting heart rate reduction compared to others, with significant effects up to 24 hours post-dose. This highlights key differences in beta blocker duration of action.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
Background:
- Beta blockers are widely prescribed for cardiovascular conditions.
- Understanding their duration of action is crucial for effective patient management.
- Serum half-life is a key determinant of a drug's duration of effect.
Purpose of the Study:
- To evaluate the impact of serum half-life on the 24-hour heart rate reduction efficacy of beta blockers.
- To compare the sustained effects of nadolol, atenolol, and pindolol.
Main Methods:
- Two studies were conducted, including a randomized, double-blind, crossover study.
- Measurements included heart rate, double product, and ambulatory electrocardiography over 24 hours.
- Drug plasma levels and half-lives were analyzed.
Main Results:
- Nadolol (15.5 hr half-life) and atenolol showed significant heart rate reduction up to 24 hours, unlike pindolol (5.5 hr half-life).
- At 24 hours post-dose, nadolol maintained 80-100% of its heart rate-attenuating effect, compared to 20-45% for atenolol.
- Nadolol exhibited greater suppression of heart rate and double product at 24 hours than atenolol.
Conclusions:
- Significant variations in the duration of action exist among beta blockers.
- Serum half-life is a critical factor influencing the sustained efficacy of beta blockers.
- Nadolol offers a more prolonged heart rate-lowering effect compared to atenolol and pindolol.